Recent

% | $
Quotes you view appear here for quick access.

ANI Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dudley5538 dudley5538 Apr 25, 2012 11:46 AM Flag

    Teva Partnership

    Read the 10-K people: The Teva royalty payment is in a holding pattern until the patent infringement suit with Abbott Laboratories terms of settlement are known. My guess is that Abbott is forcing Teva to hold off on selling the product for a few years. This is why the stock will probably continue down to the 52 low before it turns around in IMO. BPAX has no money coming in right now and nothing on the horizon. They will eventually have to sell equity, which will take a hit on the PPS.


    "Our male testosterone gel is our second FDA approved product. This product was initially developed by us, and then licensed by us to Teva for late stage clinical development. Teva submitted a new drug application (NDA) to the FDA in the beginning of 2011, which was approved by the FDA in February 2012. Subsequent to Teva submitting the NDA, in April 2011, a subsidiary of Abbott Laboratories, a marketer of a testosterone gel for men, filed a complaint against Teva alleging patent infringement. This litigation was settled in December 2011; however, the terms of the settlement agreement are confidential and have not been publicly disclosed. To the extent Teva has agreed with the subsidiary of Abbott Laboratories to delay the commercial launch of our male testosterone gel, the settlement agreement could delay our receipt of royalties based on sales of our male testosterone gel by Teva."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Dudley,

      Hey what with all the #'s after your YA ID ?

      The 10k more specifically says this .......CEO just mentioned he is not sure when Teva will launch...Your "guess" Teva will hold off a few years before launching??? what do you base your "guess on "

      ""however, the terms of the settlement agreement are confidential and have not been publicly disclosed. To the extent Teva has agreed with the subsidiary of Abbott Laboratories to delay the commercial launch of our male testosterone gel, the settlement agreement could delay our receipt of royalties based on sales of our male testosterone gel by Teva."""

      There nothing written in stone here, and nothing to suggest years off !

      Just read what it really says,

    • lol, listen to the recent Simes interview people. How quickly we Americans forget everything...it always amazes me!

    • Try reading my question - wasn't talking about Royalty Payments and we are all aware it's on hold.

 
ANIP
68.12+0.580(+0.86%)Apr 20 4:00 PMEDT